ARTICLE | Company News
AntiCancer other research news
May 13, 2002 7:00 AM UTC
Researchers published in Head and Neck that HDRA was effective for in vitro drug response assessment of individual cancer patients. Tumor specimens from 41 of 42 patients undergoing treatment for head...